Adjuvant Chemotherapy with Gemcitabine for Resected Biliary Tract Cancer: A Single-Arm Phase II Study
Phase 2
- Conditions
- histologically verified biliary tract cancer (BTCs) with macroscopic complete resection
- Registration Number
- JPRN-UMIN000014018
- Lead Sponsor
- Shinshu University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 55
Inclusion Criteria
Not provided
Exclusion Criteria
Exclusion criteria included contracting active infection, syncronous cancer, pregnancy or lactation, a history of severe drug allergy and other severe comorbid diseases including hemopericardium or symptomatic brain metastasis.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method